The pharmaceutical company Merck on Tuesday sued the government over a federal law that empowers Medicare for the first time to negotiate prices directly with drugmakers.Merck’s lawsuit, filed in federal court in Washington, is the drug industry’s most significant move so far to fight back against a substantial change to health policy, which will go into effect starting in 2026. Democrats pushed through the Medicare-negotiation program last summer as a provision of the Inflation Reduction Act, framing it as a way of lowering drug prices.Only some drugs will be subject to negotiation with Medicare and only after they have been on the market without competition for years. But Merck, which generated $14.5 billion in profit last year, claimed in a statement on Tuesday that the law would stifle its ability and that of its peers to make risky investments in new cures.Other drug companies have suggested t …
Browse
Business Central
Accelerate growth with 1BusinessWorld's Global Business Profile
Sign up for free or use coupon code 1BW50 for 50% discount on your subscription
Sign up nowLatest Business News
- Precision Health and Personalized Medicine: The Blueprint for an Inclusive Future in Health Care (11/4/2024) - How Tailored Treatments and Proactive Health Strategies are Shaping a… Read more...
- Precision Health: The Strategic Frontier for Transforming Healthcare Investments (11/4/2024) - At the Precision Health Summit, industry leaders reveal how AI-driven… Read more...
- Harnessing Storytelling for Sustainable Change (10/31/2024) - How Authentic Narratives Drive Engagement, Inspire Action, and Advance Sustainability… Read more...
- Greening the Stage: Transforming Music Festivals into Hubs for Sustainability (10/29/2024) - How Eco-Conscious Practices and Strategic Collaboration are Shaping the Future… Read more...
- Precision Medicine’s Promise: Transforming Healthcare into a Personalized Reality (10/29/2024) - How Strategic Partnerships, Innovative Models, and Equitable Access Can Make… Read more...
- Navigating NYC’s Real Estate Market: Strategic Leadership Amid Unprecedented Challenges (10/24/2024) - How Understanding Market Cycles and Adapting Strategies Can Transform Volatility… Read more...